INTRODUCTION
============

The mature cortex is a six-layered structure that controls complex functions, including motor coordination, and auditory, visual and somatosensory processing, as well as cognition (reviewed in [@b83-0050351]). Appropriate regulation of cell number, cell-type specification, laminar positioning and circuit formation is essential for normal functioning of the mature nervous system. Dysregulation of cortical development can lead to a variety of gross cortical malformations and psychiatric disorders, including lissencephaly, periventricular heterotopia, microcephaly, epilepsy, autism and schizophrenia (reviewed in [@b4-0050351]; [@b58-0050351]; [@b79-0050351]; [@b80-0050351]; [@b91-0050351]).

The type of division a progenitor cell (PC) makes is an important mechanism in regulating cell number and fate in the cortex. Early in development, the PC population expands by symmetric divisions, resulting in the production of two progeny radial glial cells (RGCs) ([@b75-0050351]; [@b100-0050351]). At the onset of neurogenesis (∼E10.5 in mice), RGC asymmetric neurogenic divisions result in the generation of a neuroblast and an RGC ([@b35-0050351]; [@b73-0050351]; [@b75-0050351]). By mid-neurogenesis (∼E14.5 in mice) these divisions represent the predominant division type in the ventricular zone (VZ) ([@b74-0050351]). Subsequent asymmetric RGC divisions produce an RGC and an intermediate progenitor cell (IPC) ([@b35-0050351]; [@b65-0050351]; [@b74-0050351]; [@b75-0050351]). IPCs (also referred to as basal progenitors) predominately undergo symmetric terminal neurogenic division at the basal side of the VZ or within the subventricular zone (SVZ), resulting in the production of two neurons ([@b5-0050351]; [@b35-0050351]; [@b65-0050351]; [@b74-0050351]; [@b75-0050351]). Although rare, symmetric proliferative IPC divisions have also been reported, resulting in the production of two daughter IPCs ([@b65-0050351]; [@b74-0050351]). Recent studies suggest that IPCs give rise to the majority of cortical neurons, so perturbing this population during development has the potential to impact neuronal organization and ultimately behavior ([@b35-0050351]; [@b62-0050351]; [@b65-0050351]; [@b74-0050351]; [@b75-0050351]; [@b81-0050351]; [@b92-0050351]). The molecular mechanisms regulating specification, maintenance and fate of this population are just beginning to be understood.

This study investigated the role of a member of the Sall gene family, *Sall1*, in the developing brain and identifies a unique role for the *Sall1* gene in regulating PCs in the cerebral cortex. Sall1 is a C~2~H~2~ zinc-finger-containing putative transcription factor that is highly expressed in the developing CNS and peripheral organs. Previous studies have shown that members of the Sall gene family play a role in cell cycle regulation, proliferation, neuronal differentiation, migration and cell adhesion in other species ([@b7-0050351]; [@b8-0050351]; [@b16-0050351]; [@b21-0050351]; [@b22-0050351]; [@b33-0050351]; [@b34-0050351]; [@b57-0050351]; [@b87-0050351]; [@b103-0050351]). Mutation of *SALL1* in humans results in the autosomal dominant developmental disorder Townes-Brocks syndrome (TBS). These mutations are predicted to produce a truncated protein retaining the transcriptional repression domain that is hypothesized to function in a transdominant negative manner ([@b44-0050351]; [@b46-0050351]). TBS is characterized by multiple malformations with variable expression ([@b46-0050351]; [@b104-0050351]). The most common diagnostic features include imperforate anus, polydactyly, outer ear anomalies with hearing loss, and kidney abnormalities ([@b46-0050351]; [@b104-0050351]). Although cognitive alterations are only occasionally reported in TBS, it has not been investigated in depth; however, significant evidence has accumulated that indicates a role for Sall1 in neural development. First, a variety of neural and behavioral abnormalities have been described in individuals with TBS, including mental retardation, developmental delay, attention deficit hyperactivity disorder, hypoplasia of the corpus callosum, and seizures ([@b11-0050351]; [@b12-0050351]; [@b15-0050351]; [@b41-0050351]). Also, studies in mice indicate that Sall1 is highly expressed in CNS PCs from early embryonic stages ([@b13-0050351]; [@b77-0050351]). Furthermore, mice expressing a truncated Sall1 protein that recapitulates the human mutation exhibit neural abnormalities, in addition to mimicking the human deficits observed in the gastrointestinal tract, limbs and kidneys ([@b44-0050351]). These studies suggest that Sall1 might also regulate neural development.

*Sall1^−/−^* mice die at birth because of kidney abnormalities ([@b71-0050351]). In light of the robust expression of Sall1 in neural PCs and its role in neural specification in other organisms ([@b21-0050351]; [@b77-0050351]; [@b85-0050351]), we investigated the role of Sall1 in the development of the CNS. Using classical- and conditional-knockout studies, we demonstrate a unique role for Sall1 in regulating cell cycle exit and neuronal specification in the cerebral cortex. Our studies indicate that, at early developmental stages, Sall1 promotes RGC cell cycle re-entry, whereas, from mid-neurogenesis, Sall1 promotes IPC cell cycle exit. Our analyses indicate that Sall1 promotes the terminal differentiation of IPCs and the production of superficial cortical layer neurons. These findings indicate that the cerebral cortex is particularly sensitive to loss of Sall1 and that Sall1 is required to regulate progenitor cell maturation and neuronal specification in the cerebral cortex. We have identified a cellular process that might be altered in individuals with TBS and could be used as a model system to evaluate the benefits of future therapeutic intervention.

RESULTS
=======

Sall1 is expressed by cortical progenitor cells
-----------------------------------------------

In *Drosophila*, Sall has been shown to play a role in cell fate specification and neuronal differentiation ([@b21-0050351]; [@b85-0050351]). We have previously shown that, in mice, *Sall1* mRNA is expressed in the CNS, including in the telencephalon, diencephalon, hindbrain and spinal cord, from E8.5 ([@b13-0050351]; [@b77-0050351]) (note: sall1 is termed msal3 in Ott et al.). In light of the reported neural abnormalities in some individuals with TBS, a detailed expression study of the Sall1 protein in the developing forebrain of mice was performed. Expression of Sall1 protein in the early developing telencephalon mimicked the previously described *Sall1* mRNA patterns. At E9.5 and E10.5, Sall1 protein is expressed in both dorsal and ventral PCs; expression is highest in lateral and ventral regions (our unpublished observations). By E11.5, Sall1 is robustly expressed by PCs in the VZ of the dorsal cortex, with weaker expression in the medial wall ([Fig. 1A,D](#f1-0050351){ref-type="fig"}). Ventrally, Sall1 is expressed by cells in the lateral ganglionic eminence and the lateral-medial ganglionic sulcus, with weak expression in the medial ganglionic eminence ([Fig. 1A](#f1-0050351){ref-type="fig"}). By E13.5, Sall1 expression extends medially into the medial cortical wall and ventrally into the medial ganglionic eminence and preoptic area ([Fig. 1B,E](#f1-0050351){ref-type="fig"}). Sall1 was not expressed by cells in the subicular neural epithelium ([Fig. 1A,B](#f1-0050351){ref-type="fig"}). At E17.5, expression persisted in PCs and Sall1 expression was found in cells in the cortical wall ([Fig. 1C,F](#f1-0050351){ref-type="fig"}). Double labeling with neuronal markers indicated that these cells are not neurons and are most probably glial cells (data not shown).

To determine whether Sall1 was expressed in all or in a subset of PCs, we examined the colocalization of Sall1 with cell- and stage-specific markers. Double labeling with Sall1 and either bromodeoxyuridine (BrdU; pulsed for 1 hour; data not shown) or phosopho-histone H3 (PH3) indicated that Sall1 is expressed in the S-phase and M-phase of the cell cycle in RGCs at all ages examined ([Fig. 2A--C](#f2-0050351){ref-type="fig"}). Sall1 is coexpressed in close to 100% of nestin-positive ([Fig. 2D,E](#f2-0050351){ref-type="fig"}) and of Pax6-positive (data not shown) cells in the VZ, and is absent from Tbr1-positive neurons from E12.5 ([Fig. 2G](#f2-0050351){ref-type="fig"}) until birth (data not shown). IPCs can be identified from E12.5 as basal PH3-positive or Tbr2-positive cells. Sall1 is coexpressed in a subset of Tbr2-positive cells at the VZ-SVZ boundary, but is downregulated in Tbr2-positive cells in the SVZ ([Fig. 2F,H,I](#f2-0050351){ref-type="fig"}). These findings suggest that Sall1 is expressed in RGCs and is downregulated once these cells differentiate into IPCs or neurons.

The cerebral cortex is decreased in size at E18.5 in *Sall1^−/−^* animals
-------------------------------------------------------------------------

As mentioned, Sall1-deficient animals die at birth owing to kidney deficits ([@b71-0050351]). The gross anatomy of the brain and spinal cord of Sall1-mutant animals was therefore examined 1 day before birth at E18.5 ([Fig. 3A,B](#f3-0050351){ref-type="fig"} and our unpublished observations). In Sall1-deficient animals, the total length and dorsal surface area of the brain was decreased by 8% (*P*\<0.01, *n*=3) and 12% (*P*\<0.01, *n*=3), respectively, compared with controls ([Fig. 3A--D](#f3-0050351){ref-type="fig"}). This decrease was predominantly due to a decrease in the size of the olfactory bulbs ([@b33-0050351]) and a decrease in the length (by 12%; *P*\<0.05, *n*=3) and dorsal surface area (by 17%; *P*\<0.01, *n*=3) of the cerebral cortex, compared with controls ([Fig. 3A--D](#f3-0050351){ref-type="fig"}). However, no alteration in the length (*P*=0.9, *n*=3) or dorsal surface area (*P*=0.5, *n*=3) of the midbrain ([Fig. 3A--D](#f3-0050351){ref-type="fig"}) or gross anatomical abnormalities in the rest of the brain or spinal cord (our unpublished observations) were observed at all ages examined in Sall1-mutant animals, compared with controls. These data suggest that, although Sall1 is expressed in all CNS PCs, the developing cerebral cortex is particularly sensitive to the loss of Sall1.

To assess the basis of the decrease in cortical size in Sall1-mutant animals, we histologically examined serial coronal sections of the cortex at E18.5 (*n*=4; [Fig. 3E--J](#f3-0050351){ref-type="fig"}). Deficiencies were observed in both the dorsal and ventral telencephalon. The cortical plate was decreased in size in *Sall1^−/−^* animals at all rostral-caudal levels, compared with controls ([Fig. 3E--K](#f3-0050351){ref-type="fig"}). In ventral regions, the striatum was smaller in Sall1-mutant animals compared with controls ([Fig. 3F](#f3-0050351){ref-type="fig"}). In addition, an apparent increase in the number of darkly stained cells adjacent to the ventricles in both the dorsal cerebral wall and in the lateral and caudal ganglionic eminences was observed in Sall1-deficient animals compared with controls ([Fig. 3F,H](#f3-0050351){ref-type="fig"}), which suggests an increase in the number of PCs in the telencephalon.

![**Sall1 is expressed by cortical PCs.** Sall1 immunohistochemistry (red) at E11.5 (A,D), E13.5 (B,E) and E17.5 (C,F). Sections are counterstained with DAPI (blue). At E11.5, E13.5 and E17.5, strong Sall1 expression is observed in the progenitor population in the dorsal cortex and lateral ganglionic eminence (AC). Weaker expression is observed in the medial cortex at E11.5 (\*; A) and the medial ganglionic eminence at E11.5 and E13.5 (A,B). Sall1 is also expressed by a subpopulation of cells outside the progenitor population (arrows, A,B,E,F). Sall1 expression is absent from the subicular neural epithelium (S; A,B). High-power examination of the dorsal cortex indicates that Sall1 was expressed by PCs (D--F) and, at E17.5, by subsets of cells in the SVZ (F). Dorsal (DL) is up and medial (M) is right, as indicated (A). LGE, lateral ganglionic eminence; MGE, medial ganglionic eminence; VZ, ventricular zone; POA, pre-optic area; PP, preplate; CP, cortical plate; SVZ, subventricular zone; IZ, intermediate zone; SP, subplate; MZ, marginal zone. Scale bar: 75 μm (D); 125 μm (E); 200 μm (F); 300 μm (A); 600 μm (B); 1100 μm (C).](DMM002873F1){#f1-0050351}

To verify these observations, the number of cells in each layer of the dorsal cerebral wall was quantified at E18.5. Total cell number was decreased by 9% in Sall1-deficient mice compared with controls at E18.5 (supplementary material Table S1, Fig. S1). Although the number of cells in the cortical plate was decreased by 26% (*P*\<0.01, *n*=4), the number of PCs was increased by 14% (*P*\<0.01, *n*=4; [Fig. 3I--K](#f3-0050351){ref-type="fig"}). Together, these findings suggest that Sall1 is required for neurogenesis in both the dorsal and ventral telencephalon.

The decrease in the size of the cortical plate and changes in the proportion of different cell types could be due to abnormalities in proliferation, differentiation, migration or survival. We first determined whether alterations in cell survival could lead to the changes in cell number observed in the Sall1-deficient mouse cerebral cortex at E18.5. The number of activated-caspase-3-positive cells in the dorsal cerebral wall was quantified at E12.5, E14.5 and E18.5. No difference in the number of activated-caspase-3-positive cells was observed between *Sall1^−/−^* and control mice (data not shown; E12: *n*=2, *P*=0.86; E14.5: *n*=2, *P*=0.99; E18.5: *n*=4, *P*=0.15), which suggests that Sall1 is not required for cell survival.

Early born neuronal populations are overproduced in Sall1-mutant animals
------------------------------------------------------------------------

To identify the primary cellular deficit caused by loss of Sall1, the development of the dorsal cerebral wall from E11.5 until birth was examined. Cortical neurogenesis initiates at E9.5 when a subpopulation of RGCs in the dorsal cortex differentiate, producing neurons primarily destined for the preplate. Preplate neurogenesis continues until E13.5 ([@b82-0050351]; [@b93-0050351]). To identify the onset of the deficits observed in *Sall1^−/−^*animals, the number of Tuj1-positive preplate neurons and Tuj1-negative RGCs was quantified in the dorsal cortex at E11.5 and E12.5 ([Fig. 4](#f4-0050351){ref-type="fig"}). At E11.5, no significant difference in the number of RGCs or neurons was evident in*Sall1^−/−^* mice compared with controls (*n*=3, [Fig. 4C](#f4-0050351){ref-type="fig"}). However, by E12.5, a 17.6% decrease (*P*\<0.01, *n*=4) in the number of RGCs and a 24.6% increase (*P*\<0.05, *n*=4) in the number of neurons in the preplate was observed in *Sall1^−/−^* mice compared with controls ([Fig. 4A--C](#f4-0050351){ref-type="fig"}), suggesting that early cortical PCs differentiate at the expense of re-entering the cell cycle.

![**Sall1 is differentially expressed by RGCs versus IPCs.** (A--G) Expression of phospho-histone H3 (PH), Sall1 (S1), nestin (N), Tbr2 (T2) and Tbr1 (T1) in E12.5 embryos. Sall1 is in red and other markers are in green. Double labeling (arrows) with Sall1 and PH3 (A--C) or nestin (D,E) indicates that these markers are coexpressed with Sall1 in PCs. White arrows in B and C indicate coexpression. The nestin-positive cell identified in D is magnified in E. At E12.5, Sall1 is absent from Tbr1-positive neurons (G) and present in a subset of Tbr2-positive cells (F). (H,I) Sall1 is expressed in a subset of Tbr2-positive cells at E14.5 (H) and E18.5 (I). The line in H,I represents the VZ-SVZ border.](DMM002873F2){#f2-0050351}

The preplate subsequently splits to form the subplate and marginal zone. To determine whether structures derived from the enlarged preplate were altered in Sall1-mutant animals, we examined molecular markers of the marginal zone and subplate at E14.5 and E18.5. Chondroitin sulphate proteoglycan (CSPG) is an extracellular matrix protein expressed by cells in the pia, subplate and marginal zone ([@b94-0050351]). In Sall1-mutant mice, an increase in CSPG staining was observed in the subplate and marginal zone at E14.5 (*n*=3; [Fig. 4D,E](#f4-0050351){ref-type="fig"}) and E18.5 (data not shown), compared with controls. Quantification of Tbr1-immunopositive subplate cells (see Methods) verified the increase in subplate cell number in Sall1-mutant animals at E18.5 (*n*=3, *P*\<0.01; [Fig. 5D](#f5-0050351){ref-type="fig"}). Intense staining for CSPG in pial cells makes it difficult to quantify CSPG-positive cells in the marginal zone; therefore, an independent marker of marginal zone cells was examined. Reelin is a secreted molecule expressed by Cajal-Retzius cells in the marginal zone ([@b76-0050351]; [@b90-0050351]). In Sall1-deficient mice, more reelin-expressing cells were apparent in the marginal zone at E14.5 ([Fig. 4F,G](#f4-0050351){ref-type="fig"}; *n*=4) and E18.5 (*n*=4; data not shown), compared with controls. Interestingly, these changes were accompanied by a 28.9% decrease in the number of cells in the cortical plate at E14.5 in Sall1-deficient animals compared with controls (supplementary material Table S1; *n*=3, *P*\<0.05). This implies that, in the absence of Sall1, more cells are committed to early born structures, the preplate and its derivatives (the marginal zone and the subplate), and that fewer cells are committed to the later born structures such as the cortical plate.

To verify this hypothesis, birth-dating studies were performed to determine whether the temporal order of neuronal specification was altered in the absence of Sall1. Pregnant dams were injected with BrdU on E11.5, E12.5 or E14.5, and the number and distribution of BrdU-labeled cells was examined at E18.5. The total number of cells born on E11.5 and E12.5 and present at E18.5 was increased in Sall1-mutant animals compared with controls (supplementary material Fig. S2, Table S1; E11.5: 41% increase, *n*=3, *P*\<0.05; E12.5: 26.3% increase, *n*=4, *P*\<0.01); however, the total number of cells born on E14.5 and present at E18.5 was similar between Sall1-deficient animals and controls (supplementary material Fig. S2, Table S1; *n*=3, *P*=0.1). Interestingly, the proportion of labeled cells in the cortical plate was decreased (E11.5: −45.7%, *n*=3, *P*\<0.05; E14.5: −11.8%, *n*=3, *P*\<0.01), with a concomitant increase in the subplate (E11.5: +47.8%, *n*=3, *P*\<0.05; E12.5: +15.8%, *P*\<0.05, *n*=4) or intermediate zone and PC populations (E14.5: +22.2%, *n*=3, *P*\<0.05, and +98.5%, *n*=3, *P*\<0.05, respectively) in *Sall1^−/−^* versus control animals ([Fig. 5A--C](#f5-0050351){ref-type="fig"}). The majority of cells born on E14.5 that were located within the intermediate zone at E18.5 expressed neuronal markers and were observed below the histologically distinguished subplate in Sall1-deficient animals (supplementary material Fig. S2), which suggests that cells born on E14.5 are not continuously committed to a subplate fate past their normal birth-date in *Sall1^−/−^* animals but that neuronal migration might be altered.

Sall1 regulates deep versus superficial laminar fate
----------------------------------------------------

Given the decreased size of the cortical plate and increased number of cells committed to the subplate and marginal zone, and the changes in PC number, we investigated whether the inside-out pattern of cortical neurogenesis and layer specification was preserved in Sall1 mutant mice. The expression of four markers that are expressed in sequentially more superficial layers was examined at E18.5. No alteration was observed in the position of: the layer VI marker Tbr1 (supplementary material Fig. S1A,B) ([@b14-0050351]; [@b38-0050351]; [@b39-0050351]); the layer V marker Ctip2 ([@b3-0050351]; [@b6-0050351]) (supplementary material Fig. S1C,D); Brn2, expressed by layer V and layer II/III cells, as well as PCs and the intermediate zone ([@b37-0050351]; [@b63-0050351]) (supplementary material Fig. S1E,F); or Cux1, which is expressed by cells in upper cortical layers II/III and IV, as well as cells in PCs and the intermediate zone (supplementary material Fig. S1G,H) ([@b69-0050351]). Taken together, these data suggest that loss of Sall1 does not alter cell-type specification of neurons destined for the cortical plate and that the inside-out pattern of neurogenesis is preserved.

![**The cerebral cortex is decreased in size at E18.5 in *Sall1****^−/−^***mice.** The cerebral cortex is decreased in size in Sall1-deficient animals (B) compared with controls (A) at E18.5. Measurements of brain surface area (C) and length (D) of control and *Sall1^−/−^* animals. (E--J) Nissl-stained coronal sections of the cortex at E18.5 (E--J) in control (E,G,I) and *Sall1^−/−^* animals (F,H,J). The cortical plate and striatum are decreased in size in Sall1-deficient animals (E--J). \*, ventral progenitor population (E--H). (K) Quantification of dorsal cell number in control and Sall1-mutant animals. \*, *P*\<0.05; \*\*, *P*\<0.01 (C,D,K). OB, olfactory bulb; CC, cerebral cortex; MB, midbrain; CP, cortical plate; S, striatum; DG, dentate gyrus; H, hippocampus; PC, progenitor population; IZ, intermediate zone; CP, cortical plate; MZ: marginal zone; D, dorsal; L, lateral. Scale bars: 2500 μm (in B for A,B); 100 μm (in J for I,J); 500 μm (in J for E--H).](DMM002873F3){#f3-0050351}

In light of the decrease in size of the cortical plate and changes in the properties of cells born on E14.5, when upper cortical layers are being specified, we investigated whether Sall1 regulated the temporal production of deep versus superficial layer fate. The proportion of cells born on E14.5 that gave rise to deep (BrdU+Tbr1+; layer VI) or superficial (BrdU+Cux1+; layers II/III, IV) cortical layer neurons was quantified at E18.5. In *Sall1^−/−^*animals, the proportion of cells born on E14.5 specified as deep cortical layer neurons was increased by 213.6% (*P*\<0.05, *n*=3; supplementary material Table S1), whereas the production of superficial cortical layer neurons was decreased by 28.6% (*P*\<0.01, *n*=3; supplementary material Table S1), compared with controls. By E18.5, total cell number in layer VI and superficial cortical layers were decreased by 24.5% (*P*\<0.05, *n*=3) and 35.9% (*P*\<0.05, *n*=4), respectively, in *Sall1^−/−^* animals versus controls ([Fig. 5D](#f5-0050351){ref-type="fig"}). Interestingly, when these values were expressed as a percent of total cortical plate cell number, no significant difference in the proportion of cells committed to layer VI was observed (*n*=3, *P*=0.4), whereas the proportion of cells committed to superficial cortical layers was decreased by 19.1% (*n*=4, *P*\<0.01) in *Sall1^−/−^* animals compared with controls ([Fig. 5E](#f5-0050351){ref-type="fig"}). Therefore, between E11.5 and E14.5, cells are selectively committed to a deep cortical layer fate at the expense of a more superficial cortical layer fate in *Sall1^−/−^* animals compared with controls.

Sall1 regulates cell cycle exit and IPC number during development
-----------------------------------------------------------------

The changes in the number of neurons in different cortical regions could be a consequence of disruptions in PC proliferation, differentiation and/or neuronal migration. RGCs give rise to a second proliferative population, the SVZ, which consists of IPCs, a PC population characterized by basal mitotic divisions. Recent data suggest that the majority of neurons in the cortical plate are produced via terminal neurogenic divisions of IPCs ([@b35-0050351]; [@b65-0050351]; [@b74-0050351]; [@b75-0050351]). In light of the alterations in PC and neuronal number in *Sall1^−/−^* animals, the proliferative properties of RGCs and IPCs were examined using short-term BrdU incorporation studies to determine whether Sall1 regulates PC cell cycle kinetics. These studies indicated that RGCs and IPCs were differentially altered over time in *Sall1^−/−^* mice compared with controls ([Fig. 6A](#f6-0050351){ref-type="fig"}). Timed pregnant animals were injected with BrdU on E11.5, E14.5 or E17.5, and embryos were collected 60 minutes later. The number of cells in the VZ and SVZ was calculated and the proportion labeled with BrdU calculated. The labeling index was calculated for each age and progenitor region (BrdU+/total VZ PC or BrdU+/total SVZ PC; details of cell counts are provided in the Methods). These labeling indices were identical at all ages and regions examined in control and mutant animals, indicating that the proportion of cells in S-phase of the cell cycle is not altered in the VZ or SVZ in the absence of Sall1, and suggests that Sall1 does not regulate cell cycle kinetics or the rate of proliferation of cortical progenitors ([Fig. 6B](#f6-0050351){ref-type="fig"}; E11.5: *n*=3, *P*=0.8; E14.5: *n*=4, VZ *P*=0.5, SVZ *P*=0.4; E17.5: *n*=4, VZ *P*=0.5, SVZ *P*=0.4). However, the total number of RGCs in the VZ was initially decreased at E12.5 (*n*=4, *P*\<0.01), increased by 24.8% at E14.5 (*n*=3, *P*\<0.01), and unchanged at E17.5 and E18.5 (*n*=3, *P*=0.7; *n*=4, *P*=0.2, respectively; supplementary material Table S1, Fig. S3; [Fig. 6A](#f6-0050351){ref-type="fig"}) in *Sall1^−/−^* animals compared with controls. To determine whether early IPCs require Sall1 expression, we utilized PH3 staining to identify and quantify the number of basal mitotic divisions. No significant difference in the number of basal cortical mitotic divisions was observed at E12.5 between control and *Sall1^−/−^* mice (*n*=4, *P*=0.2; data not shown), which suggests that early cortical IPCs are not altered in the absence of Sall1. Expression of the transcription factor Tbr2 can be used to identify IPCs ([@b24-0050351]). Quantifying Tbr2-positive IPC number indicated that Tbr2+ IPCs were decreased by 48.1% by E14.5 (*n*=3, *P*\<0.01), unchanged at E17.5 (*n*=3, *P*=0.7) and increased by 23% at E18.5 (*n*=3, *P*\<0.05) in *Sall1^−/−^* mice compared with controls ([Fig. 6D](#f6-0050351){ref-type="fig"}; supplementary material Fig. S4). These findings identify a role for Sall1 in regulating the production of the Tbr2+ IPC population from mid-neurogenesis.

![**Early born neuronal populations are overproduced in** ***Sall1****^−/−^* **mice.** (A,B) Tuj1 (green) staining identified an increase in preplate size at E12.5 in Sall1-deficient animals (B) compared with controls (A). (C) Quantification of cortical cell number at E11.5 and E12.5. \*, *P*\<0.05; \*\*, *P*\<0.01. (D,E) CSPG (red) immunostaining of the subplate (bracketed region) and marginal zone identified an increase in these structures in *Sall1^−/−^* mice (E) compared with controls (D) at E14.5. Note: CSPG is also expressed by the meninges at the pial surface. (F,G) Reelin (red) immunostaining identified an increase in Cajal-Retzius cells in *Sall1^−/−^*mice (G) compared with controls (F) at E14.5. (A,B,D--G) Sections are counterstained with DAPI (blue). PP, preplate; PC, progenitor population; IZ, intermediate zone; SP, subplate; CP, cortical plate; MZ, marginal zone; P, pial surface. Scale bar: 100 μm (A,B); 200 μm (D,E); 400 μm (F,G).](DMM002873F4){#f4-0050351}

![**Sall1 regulates the number of cells committed to an early born fate.** (A--C) Quantification of the proportion of total cells born (BrdU+) on E11.5 (A), E12.5 (B) or E14.5 (C) in defined cortical layers at E18.5. (D,E) Quantification of cell number in molecularly defined \[Tbr1+: subplate and layer VI (LVI); Cux1+: layers II/III, IV (LII/III,IV)\] cortical laminae at E18.5 (D) and the proportion of cells in cortical laminae as a percentage of total cortical plate cell number at E18.5 (E). \*, *P*\<0.05; \*\*, *P*\<0.01. PC, progenitor population; IZ, intermediate zone; SP, subplate; CP, cortical plate; MZ, marginal zone.](DMM002873F5){#f5-0050351}

![**Sall1 regulates cell cycle exit.** Quantification of VZ and SVZ cell number at E11.5, E12.5, E14.5, E17.5 and E18.5 in control and *Sall1^−/−^* mice (A). The labeling index was not altered in Sall1-deficient animals at E11.5, E14.5 or E17.5 compared with controls (B). The rate of neuronal differentiation (Q fraction) was increased at E11.5 (E12.5: BrdU injected at E11.5), but decreased at E14.5 (E15.5: BrdU injected at E14.5) and E17.5 (E18.5: BrdU injected at E17.5) in *Sall1^−/−^* animals compared with controls (C). Quantification of Tbr2 cell number at E14.5, E17.5 and E18.5 (D). Alterations in the rate of VZ (Pax6+) and SVZ (Tbr2+) cell cycle re-entry in *Sall1^−/−^*animals compared with controls at E14.5 and E17.5 (E). \*, *P*\<0.05; \*\*, *P*\<0.01; \*\*\*, *P*\<0.001.](DMM002873F6){#f6-0050351}

The dramatic changes identified in PCs in Sall1-deficient animals prompted us to examine the rate of neuronal differentiation. The proportion of cells that re-enter versus exit the cell cycle in a 24-hour period was quantified using long-term BrdU incorporation studies. Pregnant dams were injected with BrdU on E11.5, E14.5 or E17.5, and embryos were collected 24 hours later. The proportion of cells that differentiated into neurons was quantified (BrdU+Tuj1+/total BrdU+) and termed the quiescent-fraction (Q). Q gradually increases from 0 to 1 in control animals, whereas the proliferative fraction (P) decreases from 1 to 0 from E9.5 to E18.5 ([@b98-0050351]). At E11, Q was 0.19±0.01 in control animals and 0.24±0.02 in Sall1-deficient animals, which represents a 26.3% increase over controls ([Fig. 6C](#f6-0050351){ref-type="fig"}; *n*=4, *P*\<0.05). This finding verifies our previous results that showed increased numbers of neurons at E12.5 in Sall1-mutant animals. By E14.5, Q was 0.51±0.01 in control animals versus 0.44±0.01 in Sall1 mutants, which represents a 13.7% decrease compared with controls ([Fig. 6C](#f6-0050351){ref-type="fig"}; *n*=3, *P*\<0.05). This suggests that more cells are re-entering the cell cycle in mutants than in controls. Interestingly, the decrease in Q at E14.5 seemed to be in part due to a decrease in the previously described rapidly exiting subpopulation of cells born on E14.5 (supplementary material Fig. S3) ([@b99-0050351]). By E17.5, Q increased to 0.76±0.01 in control animals and to 0.68±0.02 in Sall1-deficient animals ([Fig. 6C](#f6-0050351){ref-type="fig"}), which represents a 10.5% decrease in Q in the absence of Sall1 compared with controls (*n*=4, *P*\<0.05). Thus, in the absence of Sall1, early PCs differentiate rather than re-enter the cell cycle, whereas, later in neurogenesis, PCs preferentially re-enter the cell cycle rather than differentiate, compared with controls.

These findings indicate that E14.5 is a critical developmental point, when Sall1 switches from promoting a proliferative fate to a differentiative fate. The early decrease (E14.5) and later increase (E18.5) in Tbr2-positive cells and the changes observed in neuronal differentiation in Sall1-mutant animals suggested that changes in the type of division that a PC makes might contribute to the observed phenotype. The proportion of E14.5 and E17.5 proliferating cells that re-entered the cell cycle and gave rise to RGCs (Pax6+) or IPCs (Tbr2+) within a 24-hour period was quantified using BrdU labeling. Although Pax6 expression does not exclusively identify RGC populations, because its expression is maintained in ∼25% of Tuj1+ newly differentiated neurons up to 20 hours after cell division, ([@b43-0050351]) and because coexpression of Pax6 and Tbr2 has been observed in cells at the VZ-SVZ border ([@b24-0050351]), intense Pax6 staining (Pax6^+++^) can be used to identify RGCs and their immediate progeny. We observed a 21.0% increase in the proportion of BrdU-labeled Pax6^+++^ RGCs (*n*=3, *P*\<0.001) with no change in the proportion of Tbr2+ IPCs (*n*=4, *P*=0.3) in *Sall1^−/−^* compared to control animals at E14.5 ([Fig. 6E](#f6-0050351){ref-type="fig"}). This suggests that, in the absence of Sall1, proportionately more PCs are undergoing proliferative RGC divisions at mid-neurogenesis. By E17.5, a 14.6% increase in the proportion of cells that re-entered the cell cycle as Tbr2+ IPCs was observed in *Sall1^−/−^* animals compared with controls (*P*\<0.05, *n*=3; [Fig. 6E](#f6-0050351){ref-type="fig"}). The fact that the proportion of cells re-entering the cell cycle as Pax6^+++^ RGCs was unchanged (*P*=0.6, *n*=3; [Fig. 6E](#f6-0050351){ref-type="fig"}) suggests that, in the absence of Sall1, proportionately more IPCs are undergoing self-renewing divisions, rather than terminal neurogenic divisions, at this age. Together, these findings indicate that Sall1 is a crucial regulator of PC maturation during development.

Sall1 expression in dorsal progenitor cells regulates progenitor cell maturation
--------------------------------------------------------------------------------

Our results point to a role for Sall1 in regulating neuronal differentiation in the dorsal cortex. However, alterations in the ventral forebrain were histologically observed in Sall1-deficient mice. Interneurons derived from the ventral telencephalon tangentially migrate to their final laminar cortical position through the SVZ, intermediate zone and marginal zone (reviewed in [@b60-0050351]). Furthermore, dorsal progenitors have been shown to molecularly interact with ventrally derived migrating interneurons ([@b102-0050351]) and it is hypothesized that migrating interneurons can influence dorsal PC differentiation ([@b36-0050351]). To determine the contribution of ventrally derived cells to the observed phenotype, we generated mice with a floxed *Sall1* allele ([@b40-0050351]; [@b110-0050351]) and restricted deletion of *Sall1* to dorsal PCs using Emx1-Cre (mutant animals are termed Sall1-cKO^Emx1^). Emx1 expression initiates at E9.5, and Emx1-driven Cre recombination is evident from E10.5 ([@b29-0050351]). Recombination is observed in the majority of excitatory neurons in the cortex, but not in interneurons ([@b29-0050351]). In order to determine whether recombination of the floxed *Sall1* allele had occurred, we examined Sall1 expression in the dorsal cortex at E12.5 ([Fig. 7A,B](#f7-0050351){ref-type="fig"}). In control animals, Sall1 expression extended into the dorsal cortex at E12.5 ([Fig. 7A](#f7-0050351){ref-type="fig"}); however, in Sall1-cKO^Emx1^ embryos, strong Sall1 expression was limited to the ventral telencephalon and did not extend beyond the cortico-striatial boundary (*n*=3; arrow, [Fig. 7B](#f7-0050351){ref-type="fig"}). Weak Sall1 expression was observed in the dorsal cortex at E12.5 in Sall1-cKO^Emx1^ animals, which might represent residual Sall1 protein present in dorsal PCs produced prior to the recombination event. However, functional deletion of *Sall1* was confirmed by E12.5 because the Sall1-cKO^Emx1^ cortical phenotype was identical to *Sall1*-null animals. An increase in the number of Tuj1-positive cells present in the dorsal cerebral cortical wall was observed in Sall1-cKO^Emx1^ mice compared with controls ([Fig. 7C,D](#f7-0050351){ref-type="fig"}). Also, similar to the *Sall1*-null animals, CSPG staining revealed an increase in the number of cells in the subplate by E18.5 in Sall1-cKO^Emx1^ animals compared with controls ([Fig. 7E,F](#f7-0050351){ref-type="fig"}). Deficits in the ventral telencephalon were not observed, as expected.

Similar to null animals, the total length and dorsal surface area of the brain was decreased by 3.6% (*P*\<0.05, *n*=3) and 5.8% (*P*\<0.05, *n*=3) at E18.5, respectively, in Sall1-cKO^Emx1^ animals compared with controls (supplementary material Fig. S5). Specifically, the cerebral hemispheres were decreased in length and dorsal surface area by 12.8% (*P*\<0.05, *n*=3) and 12.8% (*P*\<0.05, *n*=3), respectively, in Sall1-cKO^Emx1^ animals compared with controls. As expected, no alteration in the length (*P*=0.9, *n*=3) or dorsal surface area (*P*=0.9, *n*=3) of the midbrain or other brain regions were observed (supplementary material Fig. S5). We quantified the number of cells in the dorsal cortex in Sall1-cKO^Emx1^ animals and, similar to Sall1-deficient animals, observed an increase in the number of PCs (17.6%; *n*=3, *P*\<0.05) and a decrease in the number of cells in the cortical plate (23.3%; *n*=3, *P*\<0.01) at E18.5 in Sall1-cKO^Emx1^ animals compared with controls (supplementary material Fig. S5). To determine whether the increase in the number of PCs was due to an increase in the number of IPCs, we examined Tbr2 staining at E18.5. In Sall1-cKO^Emx1^ animals, an increase in the number of Tbr2-positive cells was observed in the dorsal cortex at E18.5 compared with controls (*n*=3; [Fig. 7G,H](#f7-0050351){ref-type="fig"}). These findings suggest a requirement for Sall1 expression in dorsal PCs to regulate PC maturation.

Cells born in the ventral telencephalon migrate through the intermediate zone and marginal zone during development en route to the cortex. Although we observed an increase in subplate cell number (in the intermediate zone) and reelin-positive Cajal-Retzius cell number (in the marginal zone) in *Sall1^−/−^* animals, we observed no alteration in total cell number in the intermediate zone or marginal zone in Sall1-deficient animals compared with controls. In Sall1-cKO^Emx1^ animals, we also observed an increase in subplate and marginal zone populations; however, total cell number was increased by 16.2% in the intermediate zone (16.2%; *n*=3, *P*\<0.01) and by 25.5% in the marginal zone (28.5%; *n*=3, *P*\<0.001) compared with controls at E18.5 (supplementary material Fig. S5). These data suggest that a population of ventrally derived migrating cells is decreased in *Sall1^−/−^* animals and that this deficit is rescued in Sall1-cKO^Emx1^ animals.

![**Conditional deletion of Sall1 in dorsal PCs indicates that Sall1 regulates PC fate progression.** Sall1 (red) expression is localized to the ventral telencephalon and does not extend into the dorsal cortex in Sall1-cKO^Emx1^ animals (arrow, B), unlike controls (A) at E12.5. Tuj1 staining (green) of cortical neurons at E12.5 identified an increase in preplate cell number in Sall1-cKO^Emx1^ (D) animals compared with controls (C). CSPG (red) immunostaining of the subplate and marginal zone identified an increase in these structures in Sall1-cKO^Emx1^ (F) animals compared with controls (E) at E18.5. Tbr2 (red) immunostaining at E18.5 identified an increase in IPCs in Sall1-cKO^Emx1^ (H) animals compared with controls (G). PC, progenitor population; PP, preplate; SP, subplate; CP, cortical plate; MZ, marginal zone. Scale bar: 100 μm (C,D,G,H); 350 μm (E,F); 400 μm (A,B).](DMM002873F7){#f7-0050351}

DISCUSSION
==========

These studies demonstrate that Sall1 regulates development of the cerebral cortex in mice and provide insight into neural abnormalities that might be present in individuals with TBS. Sall1 is expressed by CNS PCs throughout neurogenesis, as well as in peripheral organs. Using classical knockout studies, we identified a unique requirement for Sall1 expression in dorsal cortical PCs. At E18.5, both the surface area and depth of the cerebral cortex were decreased in size in *Sall1^−/−^* animals compared with controls. These alterations are a consequence of changes in the type of division that cortical PCs undergo. Early in development, *Sall1^−/−^*PCs preferentially exit the cell cycle, whereas later in development IPCs preferentially re-enter the cell cycle. These changes are associated with an increased commitment of neurons to an early cortical fate and a decrease in the number of neurons committed to a later cortical fate, compared with controls. These findings suggest that Sall1 temporally regulates cortical neurogenesis in cortical PCs.

Sall1 regulates neuronal output in deep versus superficial cortical layers
--------------------------------------------------------------------------

Although the inside-out pattern of laminar specification was normal in the absence of Sall1, the temporal order of deep to superficial laminar fate specification was altered. The first neuronal layer to be specified is the preplate, born from E11.5 to E12.5 in control animals, which splits to form the subplate and marginal zone at ∼E13.5 ([@b30-0050351]; [@b82-0050351]; [@b93-0050351]). Deep cortical layers (layers VI and V) are subsequently specified from E12.5 to E13.5, with production of superficial cortical layers (layers II, III, IV) predominating from E14.5 ([@b2-0050351]; [@b17-0050351]; [@b28-0050351]; [@b56-0050351]; [@b82-0050351]; [@b101-0050351]). From E11.5 to E12.5, Sall1-deficient PCs preferentially exit the cell cycle at the expense of re-entering. Birth-dating studies indicate that, early in development, proportionately more of these differentiating neurons gave rise to subplate cells at the expense of committing cells to a cortical layer fate in *Sall1^−/−^* animals. These findings suggest that early in development Sall1 promotes proliferative symmetric divisions over asymmetric differentiative divisions in RGCs and restricts neurogenesis of preplate neurons in early cortical PCs.

Interestingly, increased early neurogenesis is often associated with depletion of the PC population. As a consequence, the cortical plate is decreased in size owing to the lack of available PCs later in development ([@b9-0050351]; [@b18-0050351]; [@b32-0050351]; [@b84-0050351]; [@b106-0050351]). Our findings suggest that the decrease in cortical plate size in Sall1-mutant animals is not simply due to depletion of the PC population. Although Sall1 promotes cell cycle re-entry in early cortical PCs from E11.5 until E13.5, it facilitates cell cycle exit in late PCs. The paradoxical role of Sall1 in early versus late PCs is mediated by changes in the properties of RGCs versus IPCs and occurs as PCs transition from producing neurons with a deep layer fate to those with a superficial layer fate. We demonstrated that proportionately more PCs re-entered the cell cycle as Pax6^+++^ RGCs and fewer exited the cell cycle and differentiated into neurons in Sall1-mutant animals at E14.5, compared with controls. These findings indicate that, from E14.5, differentiative divisions were decreased and that symmetric VZ proliferative divisions were increased in *Sall1^−/−^*animals compared with controls. Interestingly, these changes were associated with a decrease in the rapidly exiting subpopulation of cells born on E14.5 ([@b99-0050351]). Birth-dating of Sall1-deficient PCs at E14.5 indicated that proportionally more PCs gave rise to deep cortical layers (Tbr1+ layer VI neurons) and proportionately fewer PCs gave rise to superficial cortical layers (Cux1+ layer II/III, IV neurons) compared with controls. Coincident with these changes in laminar specification, RGCs were increased and IPCs were decreased in Sall1-deficient animals at E14.5, compared with controls. By E17.5, however, an increase in the proportion of cells that re-entered the cell cycle as Tbr2+ IPCs was observed in *Sall1^−/−^* animals compared with controls, accompanied by a decrease in the proportion of cells that differentiated into neurons, with no change in the proportion of cells that re-entered the cell cycle as Pax6^+++^ RGCs. This suggests that *Sall1^−/−^* IPCs are undergoing symmetric self-renewing divisions at the expense of neuronal differentiation. Because early (E12.5) IPC number was normal in Sall1-deficient animals, these observations support the hypothesis that Sall1 might influence the transition from deep to superficial neuronal specification by regulating the terminal differentiation of IPCs.

A role for Sall1 in intermediate progenitor cell function
---------------------------------------------------------

It is interesting that Sall1 is highly expressed in RGCs and downregulated in IPCs yet it has a major phenotype in regulating IPC properties. What are the molecular mechanisms that could mediate the actions of Sall1 in RGCs versus IPCs? Recently, several molecules have been implicated in regulating IPC proliferation and differentiation. Tbr2 is sufficient to suppress a radial glial cell phenotype and promote an IPC phenotype ([@b92-0050351]). Disruption of Notch or Fragile-X mental retardation protein signaling promotes the transition of RGCs to IPCs ([@b66-0050351]; [@b86-0050351]; [@b109-0050351]). IPC number is decreased in the absence of either Frs2α, Foxg1 or insulinoma associated 1, which indicates that these proteins regulate the expansion of IPCs ([@b95-0050351]; [@b108-0050351]). By contrast, Cux2 has been shown to limit the proliferation of IPCs. In the absence of Cux2, an increased number of IPCs was observed at E15.5, similar to the phenotype observed in Sall1-deficient mice ([@b19-0050351]). One of the most likely signaling pathways that Sall1 could interact with is the Wnt pathway. Similar to Sall1, analysis of Wnt signaling in cortical PCs has shown that the Wnt--β-catenin pathway has differential effects on RGCs versus IPCs ([@b107-0050351]; [@b67-0050351]). A downstream mediator of the Wnt pathway, β-catenin, is predominantly expressed in RGCs and its expression must be downregulated to induce the production of IPCs ([@b68-0050351]). Interestingly, numerous studies have shown that Sall1 is activated in response to Wnt signaling and can interact with β-catenin ([@b20-0050351]; [@b21-0050351]; [@b25-0050351]; [@b89-0050351]). Sall1 might therefore mediate some of the effects of Wnt signaling in cortical PCs to control the transition from an RGC to an IPC.

Sall1- and Cux2-deficient animals both have an increased number of IPCs; however, in Cux2-deficient animals this increase was associated with an increase in the number of cells in superficial cortical layers, whereas, in Sall1-deficient mice, superficial cortical neuron number is decreased. This decrease in Sall1-mutant animals is a consequence of decreased neuronal differentiation from E14.5, as well as a decrease in the commitment of neurons to a superficial cortical layer fate. This does not exclude the possibility that the increased number of IPCs present in *Sall1^−/−^* mice at E18.5 might be continuously committed to the production of superficial cortical layers postnatally, leading to normal neuronal number in superficial layers in adults. Also, because Sall1 is predominantly expressed in radial glial cells, it is possible that Sall1 regulates migration of neurons in a non-cell-autonomous manner. These potentials could be examined by analyzing the postnatal maturation of the cerebral cortex and the final organization of cortical laminae. Alternatively, gliogenesis might be altered in Sall1-deficient mice, because glial cells are born at late prenatal and early postnatal stages. However, we have not seen any differences in glial or oligodendrocyte markers in *Sall1*-null or conditional knockout animals (our unpublished observations). In summary, our findings support the hypothesis that, from mid-neurogenesis, Sall1 promotes terminal neurogenesis of PCs, initially by controlling the transition from an RGC to an IPC and later by regulating terminal neurogenesis of IPCs.

The SALL family in human disease
--------------------------------

In summary, we identified a previously unknown role for Sall1 in regulating PC fate progression in the developing cortex. In early cortical PCs Sall1 promotes proliferative over neurogenic divisions in RGCs, whereas later in development, Sall1 promotes differentiative over proliferative divisions in IPCs. Other members of the Sall gene family have also been shown to restrict PC proliferation and must be eliminated in a cell to allow cellular differentiation in other systems. Sall1 is required for the proliferation or survival of embryonic stem cells ([@b42-0050351]) and in multipotent renal PCs in mice, but is not required for their generation or differentiation ([@b70-0050351]; [@b72-0050351]). In *Drosophila*, a *Sall1* homolog, the *Spalt* gene, has been shown to restrict the number of sensory organ precursor cells and inhibit their neuronal differentiation ([@b21-0050351]; [@b85-0050351]). The related Sall family member Sall4 is required to maintain cells in a proliferative undifferentiated state ([@b7-0050351]; [@b22-0050351]; [@b87-0050351]). Of the four mammalian Sall genes identified, expression studies indicate that they are expressed in cortical PCs as well as in distinct and overlapping structures in the developing nervous system and peripheral organs ([@b33-0050351]; [@b34-0050351]; [@b50-0050351]; [@b51-0050351]; [@b77-0050351]) (and our unpublished observations). Mutations in three of these genes are associated with known human disorders with neural abnormalities and overlapping phenotypes in peripheral organs, including TBS (SALL1), Okihiro syndrome/Duane radial ray syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome (SALL4) and 18q deletion syndrome (SALL3) ([@b1-0050351]; [@b47-0050351]; [@b52-0050351]; [@b46-0050351]). Many of the mutations identified in individuals with TBS are located in exons 2 and 3 and in intron 2 of *Sall1*, and are predicted to lead to premature termination of transcription ([@b10-0050351]; [@b23-0050351]; [@b48-0050351]; [@b53-0050351]; [@b49-0050351]; [@b46-0050351]; [@b61-0050351]; [@b88-0050351]; [@b96-0050351]; [@b105-0050351]). Although it is thought that many of these transcripts will be degraded by nonsense-mediated RNA decay, recent evidence has suggested that the truncated protein can function in a transdominant negative manner ([@b44-0050351]; [@b45-0050351]). These findings indicate that, in humans, TBS could be caused by a gain of function. However, deletions of *SALL1* have also been identified in some individuals with a milder form of TBS ([@b11-0050351]), indicating that haploinsufficiency can also lead to the disorder. It is therefore likely that the differences seen in the two phenotypes observed in humans and mice with either a deletion or truncation of the *Sall1* gene are due to the cell-type-specific protein interactions on target gene promoters. Previous studies demonstrated that Sall family members could interact with each other via their N-terminal region ([@b44-0050351]; [@b87-0050351]; [@b97-0050351]). Our investigations and those of other researchers have found that the related family members Sall2, Sall3 and Sall4 are also expressed in cortical neural progenitor cells ([@b59-0050351]; [@b77-0050351]; [@b78-0050351]), suggesting that Sall family members might functionally compensate for each other and/or functionally interact to regulate neurogenesis in the developing cerebral cortex. The rarity of TBS in humans and the variable penetrance of this disorder make it difficult to assign a concise neural phenotype in individuals with TBS. The findings presented here provide important insights into the role of Sall1 in neural precursors, with relevance to human neural precursors, and will provide a framework for future studies aimed at examining neural function in individuals with TBS.

METHODS
=======

Animals
-------

Embryos were obtained from the mating of *Sall1* heterozygote (*Sall1*^+/−^) animals, maintained on a C57BL/6J background, and genotyped as previously described ([@b71-0050351]). No alterations in cortical development were observed in *Sall1*^+/−^animals in our study (unpublished observations) and therefore these embryos were also used as controls. Controls (*Sall1^+/+^* or *Sall1^+/−^*mice) are jointly referred to as +/. Emx1-Cre animals ([@b29-0050351]) were genotyped by PCR for the Cre gene, using previously described conditions ([@b27-0050351]). For Sall1 expression studies, embryos were obtained from timed pregnant CD1 mice from Charles Rivers Laboratories (Wilmington, MA). The day of vaginal plug was designated as embryonic day 0.5 (E0.5). For birth-dating studies, pregnant dams were injected with BrdU (50 μg/g of body weight) at the indicated times before embryo collection. For proliferation studies, BrdU was injected 60 minutes prior to embryo collection. Embryos were collected via cesarean section from E11.5 to E18.5. Brains from E18.5 embryos were dissected from the skull prior to fixation. Embryos were either fixed in 4% paraformaldehyde (PFA; pH 7.4) and processed through increasing sucrose gradients for cryosectioning, or fixed in Carnoys solution (1:3:6 acetic acid: chloroform: 100% ethanol) and then processed through a butanol series for paraffin sectioning. PFA-fixed brains were embedded in Tissue-Tek Optimal Cutting Temperature (O.C.T.) compound (EMS, Hatfield, PA) and sectioned at 20 μm. Paraffin-embedded embryos were sectioned at 10 μm. Animal protocols and procedures were approved by the Institutional Animal Care and Use Committee at the University of Pittsburgh and adhered to the National Institutes of Health guidelines.

Measurement of cortical size
----------------------------

Brains from E18.5 embryos were dissected from the skull and fixed overnight in 4% PFA. Brains were visualized on a Nikon (Melville, NY) dissecting microscope, photographed with a Photometrics (North Reading, MA) CoolSNAP digital camera and IP Lab software (Biovision Technologies, Exton, PA). Images were subsequently imported into Photoshop 7.0 (Adobe Systems, San Jose, CA). Analyses were performed by an observer blind to the genotype. Total brain length was measured as the distance from the rostral extent of the olfactory bulb to the caudal extent of the inferior colliculus. Cortical length was measured as the distance from the rostral extent of the cortex to the caudal extent of the cortex, at the lateral edge of the olfactory bulb. Midbrain length was measured as the distance from the rostral extent of the superior colliculus to the caudal extent of the inferior colliculus. Surface area was analyzed in similarly defined regions. Statistical analysis was performed using an unpaired *t*-test with InStat 3 software (GraphPad Software, San Diego, CA).

Immunohistochemistry
--------------------

Immunohistochemistry and Nissl staining was performed as previously described ([@b33-0050351]; [@b84-0050351]), with the following antibodies: mouse anti-BrdU (1:25, Amersham Biosciences, Piscataway, NJ); rabbit anti-Brn2 (1:500, Santa Crux Biotechnology, Santa Cruz, CA); rabbit anti-activated-caspase-3 (1:200, Promega, Madison, WI); mouse anti-CSPG (1:5, Developmental Studies Hybridoma Bank, The University of Iowa, IA); rat anti-Ctip2 (1:500, Abcam, Cambridge, MA); rabbit anti-Cux1 (Santa Crux Biotechnology); chicken anti-nestin (1:500, Thermo Scientific); rabbit anti-Pax6 (1:500, Covance, Berkeley, CA); rabbit anti-PH3 (1:200, US Biological, Swampscott, MA); mouse anti-reelin (1:500, Abcam); mouse anti-Sall1 (1:500, PPMX Perseus Proteomics, Tokyo, Japan); rabbit anti-Tbr1 (1:1000, Chemicon, Temecula, CA); rabbit anti-Tbr2 (1:1000, Chemicon); rabbit anti-Tuj1 (1:1000, Sigma, St Louis, MO). Sections were visualized on a Nikon fluorescent microscope, photographed with a Photometrics CoolSNAP digital camera and IP Lab software. Composite images were prepared using Photoshop 7.0. Contrast, color and brightness were adjusted in Photoshop 7.0.

Histological identification of cortical layers
----------------------------------------------

To assign cellular subtypes and boundaries to cortical layers, sections were examined at 40× magnification. The VZ was identified as the cellular region that is adjacent to the ventricle and contains organized parallel arrays of cells with elongated nuclei arranged perpendicular to the ventricular surface. The SVZ was composed of a compact layer of cells with round nuclei arranged in a disorganized manner, adjacent to the VZ. In this study the progenitor population was defined to include the VZ and SVZ. The intermediate zone was cell sparse compared with the progenitor population and contained a mixture of cells with round and elongated nuclei arranged both parallel and perpendicular to the ventricular surface. The subplate was identifiable within the intermediate zone as a layer of large round nuclei, deep to the cortical plate. The cortical plate was evident from E14.5 and identifiable owing to an increased packing density of round cell nuclei arranged in rows. The marginal zone was located superficial to the cortical plate, adjacent to the pial surface. The marginal zone contained a mixture of cells with round nuclei and elongated nuclei arranged parallel to the ventricular surface.

Analysis and cell counts
------------------------

For quantification of cell number in the dorsal cortex, stained sections were imaged as described above. Sections were histologically matched for rostral-caudal level between genotype. For cell counts, matched sections through the presumptive somatosensory 1 hindlimb and forelimb region or through the presumptive somatosensory 1 trunk region were quantified ([@b26-0050351]). Cortical layers were histologically distinguished as described above. For all analyses a 150 μm window in the medial-lateral dimension spanning from the ventricular to pial surface of the dorsal cortex from three non-adjacent sections per animal were counted, and the mean of the three sections per animal was calculated. The means from three or four animals per genotype were compared i.e. three or four mutant animals were compared with three or four wild-type animals. The analyses were performed by an observer blind to the genotype. Cell counts were performed and quantified using a cell counting program, as previously described ([@b84-0050351]). The data were subsequently decoded and statistical analysis of the results was performed using an unpaired *t*-test with InStat 3 software. Graphs were prepared using Prism 4 software (GraphPad Software). Values are represented as mean ± s.e.m. Significance was set at *P*\<0.05.

Cell death studies
------------------

For studies of cell survival, the number of activated-caspase-3-positive cells spanning the ventricular to pial surface was quantified.

Proliferation studies
---------------------

Pregnant animals were injected with a single dose of BrdU (on E11.5, E14.5 or E17.5), and embryos were collected 60 minutes later and processed for immunohistochemistry. Sections were stained with an anti-BrdU antibody and counterstained with DAPI. To calculate the labeling index, the total number of DAPI-positive cells within the VZ and SVZ was counted per window. The number of BrdU-positive cells in the same window was counted and the percent labeled calculated to determine the labeling index (number BrdU positive cells/total number of DAPI-positive cells). E11.5 sections were also counterstained with the neuronal marker Tuj1 and the E11.5 VZ population was defined as the Tuj1-negative population; E14.5 and E17.5 VZ and SVZ populations were histologically distinguished using DAPI staining.

Laminar cell counts
-------------------

To determine the number of cells in each cortical layer, individual markers were used to identify distinct laminae. Cells expressing a high level of Tbr1 identify layer VI, and Cux1 expression identifies layers II/III and IV ([@b14-0050351]; [@b69-0050351]). Tbr1-positive subplate cells, located in the intermediate zone, were histologically distinguished from deep cortical plate cells by DAPI staining. The amount of Tbr1-positive or Cux1-positive cells was expressed as a percentage of total cortical plate cell number to identify whether alterations in the proportion of cells committed to deep (Tbr1+/cortical plate cell number) versus superficial (Cux1+/cortical plate cell number) layers were present in *Sall1^−/−^*mice.

Birth-dating studies
--------------------

For birth-dating studies (E18.5 embryos injected with BrdU on E11.5, E12.5 or E14.5), BrdU-stained sections were examined and only heavily labeled BrdU-positive cells were quantified. Heavily labeled cells were assumed to be cells that incorporated BrdU and subsequently exited the cell cycle. Those cells that re-entered the cell cycle will dilute the BrdU label in the nucleus and have a weaker BrdU staining. For laminar birth-dating studies, deep cortical layer VI cells were defined by high expression of Tbr1, and superficial cortical layers (layers II/III, IV) were defined by Cux1 expression. The proportion of BrdU+ cells within the cortical plate committed to a deep versus superficial layer fate was quantified: deep (Tbr1+BrdU+/BrdU+) and superficial (Cux1+Brdu+/BrdU+).

Cell cycle exit versus cell cycle re-entry studies
--------------------------------------------------

The proportion of cells that exit the cell cycle in a defined period is referred to as the quiescent fraction (Q). To identify the proportion of cells that exit the cell cycle, embryos were injected with BrdU on either E11.5, E14.5 or E17.5 and collected 24 hours later. Cells that exited the cell cycle to become neurons were identified as BrdU-positive and Tuj1-positive. Tuj1 is a pan neural marker that is expressed by neurons approximately 1 hour after they exit the cell cycle, and is maintained in migrating and mature neurons ([@b54-0050351]; [@b55-0050351]; [@b64-0050351]; [@b31-0050351]). This marker is present in cells in the VZ and SVZ and can be used to identify cells differentiating into neurons ([@b64-0050351]; [@b31-0050351]). The quiescent fraction was determined as the proportion of cells that were double positive for BrdU and Tuj1 divided by the total BrdU-positive population (BrdU+Tuj1+/total BrdU).

###### TRANSLATIONAL IMPACT

**Clinical issue**

Mutations in the human *SALL1* gene cause Townes Brocks syndrome (TBS). This condition is variably penetrant, and patients exhibit abnormalities primarily in the limbs, kidneys, ears, heart, bone, esophagus and/or anus. Various neural deficits, including mental retardation, have been identified in a small proportion of patients, although most patients are not formally examined for cognitive, emotional or behavioral alterations. Additionally, the rarity of the disorder, coupled with variable penetrance and phenotype even in individuals with similar mutations, has made it difficult to assess the impact of genetic lesions in *SALL1* on cognitive or behavioral function in humans.

**Results**

This paper identifies and characterizes a distinct phenotype involving cerebral cortical neural precursor cells in a mouse model of *Sall1* deficiency. The authors demonstrate that, although *Sall1* is expressed in all central nervous system progenitor cells, the cerebral cortex is particularly sensitive to *Sall1* deficiency in developing mice. In the absence of *Sall1*, early cortical progenitor cells exhibit enhanced neuronal differentiation, whereas later progenitor cells proliferate rather than differentiate. In addition, deficiency of *Sall1* leads to a prolonged production of neurons during development that are destined for early cortical structures such as deep cortical layers.

**Implications and future directions**

Although neural deficits are not commonly reported in individuals with TBS, these data indicate a key role for Sall1 in regulating the rate of neural cell production in the cerebral hemispheres during mouse development. Because the cerebral cortex mediates higher-order thought processing, reasoning, memory and emotion, these findings suggest that individuals with TBS have previously unrecognized neurodevelopmental abnormalities, potentially affecting neural processing, emotion and/or behavior. Future studies should examine the cognitive and behavioral consequences of either *Sall1* deficiency or expression of a disease-associated human *SALL1* allele in the mouse cerebrum, and aim to identify the associated cellular alterations. Identifying the cellular processes affected by *Sall1* deficiency or mutation might provide potential therapeutic targets in humans.

The proportion of cells that re-enter the cell cycle in a defined period is referred to as the proliferative fraction. To identify the proportion of cells that re-entered the cell cycle, embryos were injected with BrdU on either E14.5 or E17.5 and collected 24 hours later. PC cycle re-entry was determined as the proportion of cells that were double positive for BrdU and the RGC marker Pax6 or IPC marker Tbr2 divided by the total BrdU-positive population (BrdU+Pax6+/total BrdU or BrdU+Tbr2+/total BrdU). To quantify the VZ and SVZ using molecular markers, the number of Pax6- or Tbr2-positive cells within the PC population was quantified. To quantify the IPC cell number at E12.5, the number of PH3-positive cells in abventricular regions in the progenitor domain was quantified ([@b35-0050351]).
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